Related Experiment Video
Updated: Jun 8, 2026
04:09
Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
Non-healing diabetic ulcer treated by biobeam 660
1Consulting Dermatologist, Jeevan Jyot Hospital, Pune, India.
Indian Journal of Dermatology, Venereology and Leprology
|October 16, 2010
Summary
This case report details a 75-year-old diabetic patient whose non-healing foot ulcer healed completely after one month of BIOBEAM 660 therapy. This phototherapy offers a promising treatment for chronic diabetic foot ulcers.
Area of Science:
- Dermatology
- Diabetology
- Biomedical Engineering
Background:
- Diabetic foot ulcers represent a significant complication of diabetes mellitus, often leading to poor healing and increased risk of amputation.
- Chronic non-healing ulcers pose a therapeutic challenge, necessitating innovative treatment modalities.
Purpose of the Study:
- To report a case of successful treatment of a non-healing diabetic foot ulcer using BIOBEAM 660 therapy.
- To evaluate the efficacy and safety of low-level laser therapy (BIOBEAM 660) in managing chronic foot ulcers in diabetic patients.
Main Methods:
- A 75-year-old male diabetic patient with a month-long non-healing left sole ulcer was treated.
- BIOBEAM 660 therapy was administered every alternate day for a total duration of one month.
Main Results:
- Complete healing of the ulcer was achieved within the one-month treatment period.
- No complications were reported during or after the therapy.
Conclusions:
- BIOBEAM 660 therapy demonstrated significant efficacy in promoting the healing of a chronic diabetic foot ulcer.
- This case suggests that phototherapy with BIOBEAM 660 can be a safe and effective adjunctive treatment for non-healing diabetic foot ulcers.
Related Concept Videos
01:31Diabetic Foot Ulcer
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
01:19Clinical Applications of Epidermal Stem Cells
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...